CCR5 has a critical role not only in the recruitment but also in the activation of MDSCs in tumor lesions (113), and targeting the CCR5/CCL5 axis may reduce the suppressive activity of MDSCs (114). This evidence concerns the gene CCR5 and neoplasm.